LAURUSLABS2024-01-012024-03-31 LAURUSLABS2024-01-012024-03-31 LAURUSLABS2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member LAURUSLABS2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member LAURUSLABS2024-03-31 LAURUSLABS2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LAURUSLABS2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LAURUSLABS2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LAURUSLABS2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540222 LAURUSLABS NOTLISTED Laurus Labs Limited Equity 2023-04-01 2024-03-31 2024-04-25 2024-04-18 INR Crores Yearly 14:00:00 14:45:00 2024-04-25 2024-04-25 true Cash Flow Indirect Declaration of unmodified opinion Single segment Manufacturer of Generics API, Generics FDF, Synthesis and Bio Technology 2024-01-01 2024-03-31 Audited Consolidated 14396700000.00 185300000.00 14582000000.00 5914400000.00 407600000.00 898100000.00 1611100000.00 505000000.00 1022500000.00 3150600000.00 13509300000.00 1072700000.00 0.00 1072700000.00 433500000.00 -114000000.00 319500000.00 0.00 753200000.00 0.00 0.00 0.00 -3000000.00 750200000.00 22600000.00 772800000.00 756100000.00 -5900000.00 778700000.00 -5900000.00 1077900000.00 2 1.40 1.40 0.00 0.00 1.40 1.40 0.00 0.00 0.00 Single segment 2023-04-01 2024-03-31 Audited Consolidated 50408300000.00 263400000.00 50671700000.00 24223800000.00 1109200000.00 -1008800000.00 6399300000.00 1829000000.00 3845800000.00 11909800000.00 48308100000.00 2363600000.00 0.00 2363600000.00 931100000.00 -249600000.00 681500000.00 0.00 1682100000.00 0.00 0.00 0.00 -59400000.00 1622700000.00 -28700000.00 1594000000.00 1605500000.00 17200000.00 1576800000.00 17200000.00 1077900000.00 2 40031600000.00 2.98 2.97 0.00 0.00 2.98 2.97 0.00 0.00 0.00 Other Expenses 3150600000.00 Other Expenses 11909800000.00 46200000.00 34463700000.00 4228400000.00 1783200000.00 2463000000.00 190200000.00 0.00 0.00 0.00 1239800000.00 0.00 0.00 473800000.00 1713600000.00 29700000.00 648800000.00 45520600000.00 18454100000.00 0.00 16629200000.00 1389400000.00 27100000.00 9500000.00 88200000.00 18143400000.00 0.00 1752200000.00 38349700000.00 0.00 0.00 83870300000.00 1077900000.00 40031600000.00 41109500000.00 41155700000.00 7982300000.00 0.00 1044900000.00 9027200000.00 934700000.00 570400000.00 0.00 1059500000.00 11591800000.00 17088200000.00 10512400000.00 1469500000.00 29070100000.00 1442500000.00 248100000.00 362100000.00 0.00 31122800000.00 42714600000.00 83870300000.00 0.00 -1513100000.00 -851000000.00 0.00 0.00 -385000000.00 -885200000.00 0.00 0.00 3344100000.00 0.00 0.00 0.00 3845800000.00 0.00 -100000.00 0.00 0.00 0.00 -88200000.00 0.00 56100000.00 109200000.00 0.00 0.00 0.00 0.00 19300000.00 0.00 3539700000.00 5903300000.00 0.00 -1750000000.00 0.00 1045700000.00 49300000.00 6656900000.00 -716000000.00 800200000.00 0.00 0.00 0.00 0.00 0.00 0.00 23000000.00 6783100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 56100000.00 0.00 -4000000.00 0.00 -8224200000.00 0.00 0.00 0.00 0.00 0.00 0.00 25600000.00 0.00 7577400000.00 2166900000.00 0.00 332900000.00 861800000.00 1743100000.00 0.00 0.00 2498300000.00 931000000.00 1700000.00 932700000.00 456700000.00 1389400000.00 i. Remeasurement gains/(losses) on defined benefit plans 37000000.00 i. Remeasurement gains/(losses) on defined benefit plans -12000000.00 37000000.00 -12000000.00 9200000.00 -3100000.00 Exchange differences on translating the financial statements ofn foreign operations -5200000.00 Exchange differences on translating the financial statements ofn foreign operations -19800000.00 -5200000.00 -19800000.00 0.00 0.00